Furthermore, human albumin has anti-inflammatory and antioxidant properties [15,16,17], the recognition of which has led to the initiation of a clinical trial to investigate changes to these markers in sepsis patients following administration of albumin (NCT03950778). This evidence concerns the gene ALB and Sepsis.